Capricor Therapeutics (CAPR) Short-term Investments (2016 - 2025)
Historic Short-term Investments for Capricor Therapeutics (CAPR) over the last 12 years, with Q3 2025 value amounting to $79.1 million.
- Capricor Therapeutics' Short-term Investments rose 37477.35% to $79.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.1 million, marking a year-over-year increase of 37477.35%. This contributed to the annual value of $140.2 million for FY2024, which is 46560.22% up from last year.
- As of Q3 2025, Capricor Therapeutics' Short-term Investments stood at $79.1 million, which was up 37477.35% from $99.6 million recorded in Q2 2025.
- In the past 5 years, Capricor Therapeutics' Short-term Investments registered a high of $140.2 million during Q4 2024, and its lowest value of $16.7 million during Q3 2024.
- Its 4-year average for Short-term Investments is $51.1 million, with a median of $34.1 million in 2023.
- As far as peak fluctuations go, Capricor Therapeutics' Short-term Investments plummeted by 4885.63% in 2023, and later skyrocketed by 46560.22% in 2024.
- Quarter analysis of 4 years shows Capricor Therapeutics' Short-term Investments stood at $31.8 million in 2022, then fell by 22.08% to $24.8 million in 2023, then soared by 465.6% to $140.2 million in 2024, then tumbled by 43.62% to $79.1 million in 2025.
- Its Short-term Investments stands at $79.1 million for Q3 2025, versus $99.6 million for Q2 2025 and $116.0 million for Q1 2025.